{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:22:44Z","timestamp":1771654964548,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.4158\/ep.12.1.43","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T21:37:11Z","timestamp":1365197831000},"page":"43-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Rectal Administration of Propylthiouracil in Suppository Form in Patients With Thyrotoxicosis and Critical Illness: Case Report and Review of Literature"],"prefix":"10.1016","volume":"12","author":[{"given":"Susan B.","family":"Zweig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan R.","family":"Schlosser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol J.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienne M.","family":"Fleckman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.12.1.43_bb0005","series-title":"Endocrinology","first-page":"1422","article-title":"Graves\u2019 disease","author":"Chiovato","year":"2001"},{"key":"10.4158\/EP.12.1.43_bb0010","first-page":"43","article-title":"Pharmacokinetics of propylthiouracil in children and adolescents with Graves disease after a single oral dose","volume":"3","author":"Okuno","year":"1983","journal-title":"Pediatr Pharmacol (New York)."},{"key":"10.4158\/EP.12.1.43_bb0015","first-page":"488","article-title":"Pharmacokinetics of propylthiouracil upon p.o. administration in man","volume":"18","author":"Ringhand","year":"1980","journal-title":"Int J Clin Pharmacol Ther Toxicol."},{"key":"10.4158\/EP.12.1.43_bb0020","series-title":"Drug Information for the Health Care Professional: United States Pharmacopeia DI 2000","first-page":"461","author":"Antithyroid agents","year":"2000"},{"key":"10.4158\/EP.12.1.43_bb0025","series-title":"Basic Clinical Pharmacokinetics","first-page":"67","article-title":"Interpretation of plasma drug concentrations","author":"Winter","year":"1993"},{"key":"10.4158\/EP.12.1.43_bb0030","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2165\/00003088-198106060-00001","article-title":"Clinical pharmacokinetics of antithyroid drugs","volume":"6","author":"Kampmann","year":"1981","journal-title":"Clin Pharmacokinet."},{"key":"10.4158\/EP.12.1.43_bb0035","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1210\/jcem-54-1-180","article-title":"Methimazole: an alternative route of administration","volume":"54","author":"Nabil","year":"1982","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.12.1.43_bb0040","first-page":"285","article-title":"Rectal absorption of propylthiouracil","volume":"26","author":"Bartle","year":"1988","journal-title":"Int J Clin Pharmacol Ther Toxicol."},{"key":"10.4158\/EP.12.1.43_bb0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9343(90)90130-6","article-title":"Rectal administration of propylthiouracil in the treatment of Graves\u2019 disease","volume":"88","author":"Walter","year":"1990","journal-title":"Am J Med."},{"key":"10.4158\/EP.12.1.43_bb0050","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/thy.1995.5.403","article-title":"Rectal administration of iodide and propylthiouracil in the treatment of thyroid storm","volume":"5","author":"Yeung","year":"1995","journal-title":"Thyroid."},{"key":"10.4158\/EP.12.1.43_bb0055","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/00007611-199711000-00018","article-title":"Duodenal obstruction in thyroid storm","volume":"90","author":"Cansler","year":"1997","journal-title":"South Med J."},{"key":"10.4158\/EP.12.1.43_bb0060","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1089\/105072502320288500","article-title":"Rectal administration of propylthiouracil in hyperthyroid patients: comparison of suspension enema and suppository form","volume":"12","author":"Jongjaroenprasert","year":"2002","journal-title":"Thyroid."},{"key":"10.4158\/EP.12.1.43_bb0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1010004218052","article-title":"Iodine effects on the thyroid gland: biochemical and clinical aspects","volume":"1","author":"Burman","year":"2000","journal-title":"Rev Endocr Metab Disord."},{"key":"10.4158\/EP.12.1.43_bb0070","series-title":"UpToDate","article-title":"Thyroid storm","author":"Ross","year":"2004"},{"key":"10.4158\/EP.12.1.43_bb0075","series-title":"Program and abstracts of the 77th Annual Meeting of The Endocrine Society, June 14-17","first-page":"P3","article-title":"Intravenous administration of propylthiouracil in treatment of a patient with Graves\u2019 disease","author":"Gregoire","year":"1995"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20406949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20406949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/D52Q951LVDN5V250.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:46:27Z","timestamp":1761515187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20406949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S1530891X20406949"],"URL":"https:\/\/doi.org\/10.4158\/ep.12.1.43","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rectal Administration of Propylthiouracil in Suppository Form in Patients With Thyrotoxicosis and Critical Illness: Case Report and Review of Literature","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.12.1.43","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}